Advertisement
UK markets close in 2 hours 25 minutes
  • FTSE 100

    8,143.44
    -0.69 (-0.01%)
     
  • FTSE 250

    19,927.30
    -38.09 (-0.19%)
     
  • AIM

    764.13
    +3.39 (+0.45%)
     
  • GBP/EUR

    1.1688
    -0.0019 (-0.16%)
     
  • GBP/USD

    1.2488
    -0.0008 (-0.06%)
     
  • Bitcoin GBP

    46,263.43
    -2,670.94 (-5.46%)
     
  • CMC Crypto 200

    1,249.28
    -89.78 (-6.71%)
     
  • S&P 500

    5,035.69
    -80.48 (-1.57%)
     
  • DOW

    37,815.92
    -570.17 (-1.49%)
     
  • CRUDE OIL

    80.69
    -1.24 (-1.51%)
     
  • GOLD FUTURES

    2,309.40
    +6.50 (+0.28%)
     
  • NIKKEI 225

    38,274.05
    -131.61 (-0.34%)
     
  • HANG SENG

    17,763.03
    +16.12 (+0.09%)
     
  • DAX

    17,932.17
    -186.15 (-1.03%)
     
  • CAC 40

    7,984.93
    -80.22 (-0.99%)
     

23andMe CEO Wojcicki considering taking firm private, filing shows

(Reuters) - 23andMe co-founder and chief executive Anne Wojcicki is considering making an offer to buy the genetics testing company in a potential go-private transaction, a regulatory filing on late Wednesday showed.

Last week, Wojcicki notified members of the board's special committee that she is considering a potential go-private transaction for 23andMe and indicated that she would begin speaking to partners and financing sources.

23andMe declined to comment on the filing and Wojcicki did not immediately respond to a Reuters' request for comment.

Last year, the company informed several customers of a data breach in the "DNA Relatives" feature that allowed them to compare ancestry information with users worldwide.

ADVERTISEMENT

23andMe, best known for its saliva-based test kits that offer users a glimpse into their genetic ancestry went public in 2021 through a blank-check firm, backed by Virgin Group founder Richard Branson, in a deal that valued the merged entity at $3.5 billion.

(Reporting by Mrinmay Dey in Bengaluru; Editing by Eileen Soreng)